Report Company Directory

Spirax-Sarco Engineering PLC

• Day 3 - Tweets and Quotes by BNP Paribas Exane
• LIVE FEEDBACK FROM BNPP EXANE CEO CONFERENCE by BNP Paribas Exane
• Equity Strategy "Budget boost for 'reshoring' and 'electrification'" Fowler by UBS AG
• UK Midcap by HSBC
• Tariffs on the EU - thoughts by BNP Paribas Exane
• Still not firing on all cylinders by BNP Paribas Exane
• Spirax Group (SPX LN) by HSBC
• First Read: Spirax Group PLC "Trading in the first four months of the year..." by UBS AG
• Q1’25 trading update - Chinese demand softness results in underwhelming start to 25 by BNP Paribas Exane
• European Contextual Diary "The Week Ahead" Agarwal by UBS AG

Spire Corp.

SPIRE GLOBAL INC

• SPIR | Adjusting Estimates and Price Target for Reverse Stock Split by Raymond James
• InsiderInsights.com Daily Ratings Report: August 24, 2023 by InsiderInsights.com
• Telecommunications Services | 2023 Park City Summer Summit Takeaways by Raymond James
• SPIR | Reiterate Outperform; Strong 2Q23 and Staying the Path to Positive FCF by Raymond James
• SPIR | Beat 2Q23, Turning Positive Adj. EBITDA Soon by Raymond James
• An "AI" Deep Dive Across Tech, The Economy And Equities (NVDA, MSFT, GOOG, EQIX, CRM, ANET, AMT, etc…) by Raymond James
• Telecommunications Services | TMTalk: Two Former SPACs, Two Shareholder Approvals by Raymond James
• SPIR | Reiterate Outperform; Committed to >70% GAAP Gross Margins and Positive FCF Timeline by Raymond James
• SPIR | Slight Beat 1Q23, Unchanged 2023G and Timeline to +FCF by Raymond James
• SPIR | SPIR-ing Cleaning; One Issue Resolved, One Remains Outstanding by Raymond James

SPIRE GLOBAL INC

• SPIR | Reiterate MO2, Lower PT to $11; Another Quarter Closer to +FCF by Raymond James
• SPIR | Positive Adj. EBITDA (1/2Q24) and FCF (2Q/3Q24) Getting Closer by Raymond James
• InsiderInsights Weekly Report: September 9, 2023 by InsiderInsights.com

Spire Healthcare Group PLC

• Medtech Monthly "May the odds be in your favour" Doyle by UBS AG
• Medtech Monthly "April showers, but don't expect May flowers" Doyle by UBS AG
• Medtech Monthly "Beware the Slides of March" Doyle by UBS AG
• Spire Healthcare Group: 1 director by SmartInsider
• Hardman & Co Monthly: January 2025 by Hardman & Co
• Hardman & Co Healthcare Index: 2024 – Tough year for Life Sciences by Hardman & Co
• Save the Date: Barclays: Clinicians in the City 2025 by Barclays
• European Medical Technology & Services: 2025 outlook: 5 themes for '25 by Barclays
• Reminder: Straumann C-Suite fireside chat *IN ONE HOUR* (1PM UKT) by Barclays
• Reminder: Straumann C-Suite fireside chat *TODAY* by Barclays